Introducing a mobile-connected umbilical doppler device (UmbiFlow™) into a primary care maternity setting : does this reduce unnecessary referrals to specialised care? results of a pilot study in Kraaifontein, South Africa
dc.contributor.author | Mufenda, Josef | en_ZA |
dc.contributor.author | Gebhardt, Stefan | en_ZA |
dc.contributor.author | Van Rooyen, Rita | en_ZA |
dc.contributor.author | Theron, Gerhard | en_ZA |
dc.date.accessioned | 2016-08-24T06:45:54Z | |
dc.date.available | 2016-08-24T06:45:54Z | |
dc.date.issued | 2015-11 | |
dc.description | CITATION: Mufenda, J., et al. 2015. Introducing a mobile-connected umbilical doppler device (UmbiFlow™) into a primary care maternity setting : does this reduce unnecessary referrals to specialised care? results of a pilot study in Kraaifontein, South Africa. PLoS ONE, 10(11):1-13, doi:10.1371/journal.pone.0142743. | |
dc.description | The original publication is available at http://journals.plos.org/plosone | |
dc.description.abstract | Objectives: UmbiFlow™ is a mobile-connected Doppler device that utilises a continuous waveform to measure resistance in the umbilical artery. The main aim of this pilot study was to determine whether the use of UmbiFlow™ for umbilical artery Doppler in patients with a suspected decreased symphysis fundal (SF) growth could safely lead to a decreased number of patients requiring referral to a more specialised level of care. A secondary aim of the study was to evaluate the effectiveness of UmbiFlow™ Doppler as a screening tool for concealed placental insufficiency in late bookers by using a single screening cut-off value that will be abnormal for any gestation >28 weeks. Methods: The cohort comprised two groups of patients: The first group included all follow-up patients with suspected intra-uterine growth restriction (a decreased symphysis-fundus measurement based on serial assessment) who underwent on-site UmbiFlow™Doppler testing performed by the midwife directly after the clinical examination. The second group included late bookers, where gestation was uncertain; but estimated >28 weeks based on clinical grounds. This group was comprised of unselected patients who report to antenatal care late for the first time and received an UmbiFlow™Doppler test for concealed placental insufficiency. Results: UmbiFlow™Doppler could reduce the number of false referrals to hospital by 55%. A single UmbiFlow™Doppler test in late bookers appeared to identify a group of women at moderate risk of lower birth weight babies. | en_ZA |
dc.description.uri | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0142743 | |
dc.description.version | Publisher's version | |
dc.format.extent | 13 pages | en_ZA |
dc.identifier.citation | Mufenda, J., et al. 2015. Introducing a mobile-connected umbilical doppler device (UmbiFlow™) into a primary care maternity setting : does this reduce unnecessary referrals to specialised care? results of a pilot study in Kraaifontein, South Africa. PLoS ONE, 10(11):1-13, doi:10.1371/journal.pone.0142743 | |
dc.identifier.issn | 1932-6203 (online) | |
dc.identifier.other | doi:10.1371/journal.pone.0142743 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/99450 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Public Library of Science | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Primary care (Medicine) -- Maternity | en_ZA |
dc.subject | Kraaifontein, South Africa | en_ZA |
dc.subject | Doppler ultrasound -- Device | en_ZA |
dc.subject | UmbiFlow | en_ZA |
dc.subject | Fetal growth disorders | en_ZA |
dc.title | Introducing a mobile-connected umbilical doppler device (UmbiFlow™) into a primary care maternity setting : does this reduce unnecessary referrals to specialised care? results of a pilot study in Kraaifontein, South Africa | en_ZA |
dc.type | Article | en_ZA |